Figure 1 provides a summary (Figure 1). A recent study conducted on a Chinese cohort proposed four biomarkers—adiponectin, soluble leptin receptor, resistin, and C-reactive protein—as indicators of increased breast cancer risk in obese postmenopausal women (110). Here, ADIPOQ is linked to breast carcinoma.